B CELL RESPONSES

Natural regulatory plasma cells

Subjects

It has long been known that regulatory B cells can downregulate immune responses via the secretion of IL-10 and IL-35. However, the origin and nature of such suppressive B cells were not well understood. Reporting in Immunity, Lino et al. now describe a subset of resident plasma cells that expresses LAG3 and produces IL-10 in response to toll-like receptor (TLR) stimulation.

Previous studies had sought to define regulatory B cells by isolating known B cell subsets and assessing their suppressive capacity. The authors took a different approach. In a model of infection by Salmonella typhimurium, IL-10-producing CD138hi plasmocytes appear rapidly after infection. To characterize these cells, they analysed the transcriptome of IL-10+CD138hi versus IL-10CD138hi cells on day 1 post infection. A number of genes encoding regulatory transmembrane receptors were found to be overexpressed in the IL-10+ cells, including LAG3, which is also a marker for IL-10 producing T regulatory type 1 cells. LAG3+CD138hi cells were found to produce high levels of IL-10 and had typical plasma cell features, like plasmacytoid morphology, spontaneous antibody secretion and a non-proliferative state.

Credit: JUAN GAERTNER/SCIENCE PHOTO LIBRARY/Getty

The rapid emergence of these cells was surprising, given that plasma cell differentiation normally requires proliferation over several days. This led the authors to investigate whether LAG3+CD138hi cells were already present in naive mice — which was indeed the case. Plasma cell differentiation also requires antigen stimulation. Since LAG3+CD138hi cells were also found in mice housed under germ-free or specific pathogen-free conditions, it is likely that they were induced by self-antigen.

Genome-wide methylome analysis, as well as transcriptome and gene-set enrichment analysis of CD138hi cells from naive mice and from mice 1 day post infection, confirmed that LAG3+CD138hi cells are the precursors of IL-10+LAG3+CD138hi cells. It also confirmed that they are in a quiescent state and epigenetically primed for IL-10 expression. Notably, these cells also expressed PD-L1, PD-L2 and CD200, indicating that they can operate multiple immune suppressive mechanisms.

In vivo, LAG3+CD138hi cells were shown to rapidly upregulate IL-10 expression, in a polyclonal fashion, in response to infection. By crossing LAG3–/– mice with Il10eGFP mice and generating mixed bone marrow chimeras, the authors demonstrated that LAG3+CD138hi cells control the expansion of LAG3CD138hi plasma cells in a LAG3-dependent manner. LAG3+CD138hi cells did not display an amplified response upon re-challenge or undergo isotype switching, indicating that they do not acquire features of memory cells.

Adoptive transfer experiments of different B cell subsets into Rag2–/– mice, as well as cell fate mapping, indicated that LAG3+CD138hi cells can develop from several different B cell subsets and that they have a distinct B cell receptor (BCR) repertoire. Their frequency is strongly reduced in Btk–/– mice, which have defective BCR signalling. In contrast, mice deficient for TLR signalling, CD40 or the αβ T cell receptor, had normal numbers of these cells. This suggests that the development of LAG3+CD138hi cells is BCR-dependent but does not require TLR signalling or T cell help. However, the induction of IL-10 expression was found to be strictly dependent on TLR signalling (except in the bone marrow, where some LAG3+CD138hi cells constitutively expressed IL-10).

Further experiments showed that LAG3+CD138hi cells were also less abundant in mice deficient for CD19, a positive regulator of BCR signalling, and more abundant in mice lacking CD72, which negatively regulates BCR signalling. CD72–/– mice had impaired immunity against salmonella, which could be reversed by treatment with anti-IL-10 or anti-IL-10 receptor.

“LAG3+CD138hi cells … rapidly upregulate IL-10 expression … in response to infection”

Together, these results indicate that LAG3+CD138hi cells are natural regulatory plasma cells that rapidly provide a first layer of B cell-mediated immune regulation in response to TLR signals. The authors observed that frequencies of LAG3+CD138hi cells in mice increase with age, leading them to speculate that they may react against antigens released by damaged cells. This may provide a feedback mechanism that senses the number of damaged cells, downregulating immunity accordingly.

References

Original article

  1. Lino, A. C. et al. LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells. Immunity 49, 120–133 (2018)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alexandra Flemming.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Flemming, A. Natural regulatory plasma cells. Nat Rev Immunol 18, 540–541 (2018). https://doi.org/10.1038/s41577-018-0057-8

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing